EX-99.3 18 ny20006674x9_ex99-3.htm EXHIBIT 99.3

 

 

Exhibit 99.3

 

DIRECTOR CONSENT

 

I hereby consent to serve as a director of Angion Biomedica Corp. (the “Company”), if elected as such, and to be named as a nominee or potential nominee for director of the Company in any registration statement filed by the Company under the Securities Act of 1933, as amended, including all amendments and post-effective amendments or supplements thereto and any prospectus and/or proxy statement contained therein.

 

  /s/ Assaf Segal
  Name: Assaf Segal
  Date: March 29, 2023